Robert J Bitterman, Chairman, Pres. & CEO at Phio Pharmaceuticals, bought PHIO on Jun 26, 2026
Data as of Oct 16
▲ BUY$9.9K10,000 shares at $0.99Robert J Bitterman Chairman, Pres. & CEOPHIO Phio Pharmaceuticals Corp.
- Traded
- Jun 26, 2026
- Disclosed
- Jun 29, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PHIO since disclosure
−11.6%
Similar stocks (XLV) since disclosure
+9.9%
XLV — its sector index fund
Change in closing price from Jun 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.